It looks like you're new here. If you want to get involved, click one of these buttons!
The COVID-19 vaccine will first made available to the frontline workers including the ER's doctors and nurses, firemen and police, teachers, and military personnel. Hopefully there is sufficient dosage for the general population. There are a number of vaccine candidates which passed Phase II trial on human safety and efficacy. Moderna and Pfizer are in Phase III testing now involving 30-50K patients. It will take time to sort out the data before they launch to make billions of dosages and distribute them to the general population. It is also likely several different vaccines will be available to ensure robustness of the immunization program. Question is can the manufacturers deliver the vaccines on a timely basis?The vaccine 'promise' won't matter because at this point, not enough people are going to take it. feh. Wifey and I got our flu shots day before yesterday, but I won't get a Covid-19 shot at least until fall of 2021 and maybe not then. I no longer trust anything coming out of Washington and the FDA. Any vaccine they approve will be on a scale with injecting rat poison or drinking bleach. I did hear someone suggest paying Americans $1000 each to get the shot and this is actually a very good idea. You get immunization AND stimulate Aggregate Demand.
https://axios.com/united-airlines-layoffs-voluntary-leave-e4ae7003-9644-44cc-adca-4fea75993a65.htmlUnited Airlines said Wednesday it expects to cut 16,370 jobs on Oct. 1, far fewer than the 36,000 it warned of two months ago, as suspense builds over whether Congress will extend relief for the struggling airline industry.
PIMIX is significantly leveraged as well. Over half the ER, 0.59% out of 1.09%, goes toward paying interest (per summary prospectus).Yield’s getting harder this year. Unless you can stand volatility via leverage perhaps in a CEF or something like XOM or XLE.
Pretty much all of the top holdings are either futures or swaps. Fund data and research providers, like Morningstar, as well as most institutional investors, are not capable of netting those swap positions against thousands of bonds, some of which are not easily priced. It is worth noting that the sum of top 10 derivatives positions is negative 32% and, on top of that, the fund turns over its entire portfolio every other month (472% turnover), rendering intermittently disclosed holdings snapshots useless.
Hi Rforno, yes, very I’m intrigued by NUSI, also DRSK. I think the focus articles on TMSRX make it attractive too. Any thoughts on best fit for a taxable account(not looking for income)? I’m having trouble understanding how options distributions are characterized. So far, I’m happy with SWAN.
Best of luck,
Rick
Nice to know. Include these as 401K choices and let investors decide what to do. I'm fine with that :-)
© 2015 Mutual Fund Observer. All rights reserved.
© 2015 Mutual Fund Observer. All rights reserved. Powered by Vanilla